Rethinking Hormone Therapy
In November 2025, the FDA removed the “black box warning” from medications used for menopausal hormone therapy, a decision that was immediately described as historic. A black box warning indicates serious health risks and strict prescribing limitations. Risk information has now been moved to the prescribing information rather than appearing on the frontal packaging. The […]
